Search

Author/Creator Dejgaard, Thomas F.

1. Effect of short‐acting exenatide administered three times daily on markers of cardiovascular disease in type 1 diabetes: A randomized double‐blind placebo‐controlled trial. Issue 9 (16th June 2020)

Authors:
Johansen, Nicklas J.; Dejgaard, Thomas F.; Lund, Asger; Schlüntz, Camilla; Larsen, Emil L.; Poulsen, Henrik E.; Goetze, Jens P.; Møller, Holger J.; Vilsbøll, Tina; Andersen, Henrik U.; Knop, Filip K.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 22:Issue 9(2020)
Page Start:
1639
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Effects of short‐acting exenatide added three times daily to insulin therapy on bone metabolism in type 1 diabetes. Issue 2 (18th October 2021)

Authors:
Johansen, Nicklas J.; Dejgaard, Thomas F.; Lund, Asger; Schlüntz, Camilla; Hartmann, Bolette; Holst, Jens J.; Vilsbøll, Tina; Andersen, Henrik U.; Knop, Filip K.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 24:Issue 2(2022)
Page Start:
221
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Efficacy and safety of liraglutide in type 1 diabetes by baseline characteristics in the ADJUNCT ONE and ADJUNCT TWO randomized controlled trials. Issue 12 (28th September 2021)

Authors:
Dejgaard, Thomas F.; von Scholten, Bernt J.; Christiansen, Erik; Kreiner, Frederik F.; Bardtrum, Lars; von Herrath, Matthias; Mathieu, Chantal; Madsbad, Sten
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 23:Issue 12(2021)
Page Start:
2752
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Liraglutide as adjunct to insulin treatment in type 1 diabetes does not interfere with glycaemic recovery or gastric emptying rate during hypoglycaemia: A randomized, placebo‐controlled, double‐blind, parallel‐group study. Issue 6 (17th March 2017)

Authors:
Frandsen, Christian S.; Dejgaard, Thomas F.; Andersen, Henrik U.; Holst, Jens J.; Hartmann, Bolette; Thorsteinsson, Birger; Madsbad, Sten
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 19:Issue 6(2017)
Page Start:
773
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Liraglutide changes body composition and lowers added sugar intake in overweight persons with insulin pump‐treated type 1 diabetes. Issue 2 (17th October 2021)

Authors:
Schmidt, Signe; Frandsen, Christian S.; Dejgaard, Thomas F.; Vistisen, Dorte; Halldórsson, Thórhallur; Olsen, Sjudur F.; Jensen, Jens‐Erik B.; Madsbad, Sten; Andersen, Henrik U.; Nørgaard, Kirsten
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 24:Issue 2(2022)
Page Start:
212
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Liraglutide reduces hyperglycaemia and body weight in overweight, dysregulated insulin‐pump‐treated patients with type 1 diabetes: The Lira Pump trial—a randomized, double‐blinded, placebo‐controlled trial. Issue 4 (19th December 2019)

Authors:
Dejgaard, Thomas F.; Schmidt, Signe; Frandsen, Christian S.; Vistisen, Dorte; Madsbad, Sten; Andersen, Henrik U.; Nørgaard, Kirsten
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 22:Issue 4(2020)
Page Start:
492
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗